Sino Biopharma- Double three in action.

1177

Current wave analysis suggests that the stock has already completed a regular flat and zig-zag action.
Price action suggest that the stock is heading for further downside correction as rising wedge formation gave some hint that the stock is losing its steam on bullish momentum.
Thursday bullish pin bar/hammer is considered failed as the bullish rally on Friday (14th Feb) is rejected at the final hours, forming a bearish hammer below the supply region, which confluent with the 78.6% of the Fibonacci level.